December 4, 2025
On December 2, the Vaccine Integrity Project (VIP) released a study on the safety, effectiveness, and public health impact of hepatitis B virus (HBV) vaccinations at birth.
VIP, a project by the Center for Infectious Disease Research and Policy (CIDRAP) at the University of Minnesota, released the report two days before the Advisory Committee on Immunization Practice (ACIP) was scheduled to meet to discuss whether to end the practice of vaccinating all newborns for HBV. The practice has been in place since 1991.
VIP found the following in its review of data:
Given the long-term protection provided by the hepatitis B vaccine, the birth dose was also key in reducing HBV transmission, disease, and death in the U.S. overall.
No safety benefits were identified for a delayed first dose versus vaccination at birth.
Delaying the first dose leaves infants vulnerable to both undiagnosed maternal infection and HBV exposure after birth.
The data review found no benefit of delaying vaccinations.
See the full report here.
December 4, 2025
On December 4, Minnesota Management and Budget (MMB) released its budget forecast for the 2026-27 biennium, showing a short-term budget surplus of $2.5 billion for the current biennium, but warned of a long-term $2.96 billion deficit for the 2028-29 biennium.
December 4, 2025
On December 2, the Vaccine Integrity Project (VIP) released a study on the safety, effectiveness, and public health impact of hepatitis B virus (HBV) vaccinations at birth.
December 4, 2025
The Minnesota Department of Commerce (DOC) is now accepting public comments regarding proposed legislation to mandate insurance coverage of certain treatments.